Peter Schwarz

Summary

Affiliation: Copenhagen University Hospital
Country: Denmark

Publications

  1. pmc The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men
    Peter Schwarz
    Research Center of Aging and Osteoporosis, Department of Medicine, Glostrup Hospital, 2600 Glostrup, Denmark
    J Osteoporos 2011:259818. 2011
  2. doi Effects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis
    Peter Schwarz
    Department of Medicine, Research Center of Aging and Osteoporosis, Glostrup University Hospital, 2600 Glostrup, Denmark
    Calcif Tissue Int 90:165-73. 2012
  3. ncbi Paget's disease of the bone after treatment with Denosumab: a case report
    Peter Schwarz
    Research Center of Ageing and Osteoporosis, Department of Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark
    Bone 50:1023-5. 2012
  4. ncbi The effect of PTH(1-34) on fracture healing during different loading conditions
    Maria Ellegaard
    Research Center of Ageing and Osteoporosis, Department of Medicine and Diagnostics, Copenhagen University Hospital, Glostrup, Denmark
    J Bone Miner Res 28:2145-55. 2013
  5. pmc UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes
    Tina M Kringelbach
    Research Center of Ageing and Osteoporosis, Department of Diagnostics, Copenhagen University Hospital Glostrup, Glostrup, Denmark
    Purinergic Signal 10:337-47. 2014
  6. doi Status of drug development for the prevention and treatment of osteoporosis
    Peter Schwarz
    Copenhagen University Hospital, Research Centre of Ageing and Osteoporosis, Department of Medicine, Glostrup, Denmark
    Expert Opin Drug Discov 9:245-53. 2014
  7. doi Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo
    Susanne Syberg
    Research Centre of Ageing and Osteoporosis, Department of Medicine, Copenhagen University Hospital, Glostrup, Denmark
    J Bone Miner Res 27:2373-86. 2012
  8. pmc The P2X7 receptor: a key player in immune-mediated bone loss?
    Torben Madsen Kvist
    Research Center for Ageing and Osteoporosis, Departments of Medicine and Diagnostics, Glostrup Hospital, 2600 Glostrup, Denmark
    ScientificWorldJournal 2014:954530. 2014
  9. pmc Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures
    Niklas R Jørgensen
    Research Center for Ageing and Osteoporosis, Department of Clinical Biochemistry, Glostrup University Hospital, Glostrup, Denmark
    Eur J Hum Genet 20:675-81. 2012
  10. pmc Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
    Anne Qvist Rasmussen
    Research Centre of Ageing and Osteoporosis, Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
    J Med Case Reports 5:564. 2011

Collaborators

Detail Information

Publications10

  1. pmc The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men
    Peter Schwarz
    Research Center of Aging and Osteoporosis, Department of Medicine, Glostrup Hospital, 2600 Glostrup, Denmark
    J Osteoporos 2011:259818. 2011
    ..So far, all evidence is based on BMD increases in small RCT studies showing BMD increases comparable to those reported in postmenopausal women...
  2. doi Effects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis
    Peter Schwarz
    Department of Medicine, Research Center of Aging and Osteoporosis, Glostrup University Hospital, 2600 Glostrup, Denmark
    Calcif Tissue Int 90:165-73. 2012
    ..No age dependency was observed in the hips. In general the effect of treatment was improved with increasing dosage and duration of treatment from 6 to 36 months...
  3. ncbi Paget's disease of the bone after treatment with Denosumab: a case report
    Peter Schwarz
    Research Center of Ageing and Osteoporosis, Department of Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark
    Bone 50:1023-5. 2012
    ..We present a case of a male patient aged 86 years with GFR of 11 mL/min and Paget's disease successfully treated by Denosumab. The bone turnover and pain decreased upon treatment...
  4. ncbi The effect of PTH(1-34) on fracture healing during different loading conditions
    Maria Ellegaard
    Research Center of Ageing and Osteoporosis, Department of Medicine and Diagnostics, Copenhagen University Hospital, Glostrup, Denmark
    J Bone Miner Res 28:2145-55. 2013
    ....
  5. pmc UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes
    Tina M Kringelbach
    Research Center of Ageing and Osteoporosis, Department of Diagnostics, Copenhagen University Hospital Glostrup, Glostrup, Denmark
    Purinergic Signal 10:337-47. 2014
    ....
  6. doi Status of drug development for the prevention and treatment of osteoporosis
    Peter Schwarz
    Copenhagen University Hospital, Research Centre of Ageing and Osteoporosis, Department of Medicine, Glostrup, Denmark
    Expert Opin Drug Discov 9:245-53. 2014
    ..Several new medications for the treatment of postmenopausal osteoporosis are in the pipeline...
  7. doi Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo
    Susanne Syberg
    Research Centre of Ageing and Osteoporosis, Department of Medicine, Copenhagen University Hospital, Glostrup, Denmark
    J Bone Miner Res 27:2373-86. 2012
    ..Trabecular thickness and cortical bone parameters were unaffected. Combined, these findings indicate that long-term exposure of bone cells to clopidogrel in vivo could negatively impact bone health...
  8. pmc The P2X7 receptor: a key player in immune-mediated bone loss?
    Torben Madsen Kvist
    Research Center for Ageing and Osteoporosis, Departments of Medicine and Diagnostics, Glostrup Hospital, 2600 Glostrup, Denmark
    ScientificWorldJournal 2014:954530. 2014
    ..The aim of this review is therefore to provide evidence-based novel hypotheses of the role of ATP-mediated purinergic signalling via the P2X7 receptor in immune-mediated bone loss and -osteoporosis. ..
  9. pmc Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures
    Niklas R Jørgensen
    Research Center for Ageing and Osteoporosis, Department of Clinical Biochemistry, Glostrup University Hospital, Glostrup, Denmark
    Eur J Hum Genet 20:675-81. 2012
    ..In conclusion, an association was demonstrated between variants that reduce P2X7 receptor function and increased rate of bone loss. These data support that the P2X7 receptor is important in regulation of bone mass...
  10. pmc Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
    Anne Qvist Rasmussen
    Research Centre of Ageing and Osteoporosis, Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
    J Med Case Reports 5:564. 2011
    ..abstract:..